Solly SilwanChedidMD

PubMed

• 3 citations
  Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer
  Silwan Chedid, Edgardo Rivera, Debbie Frye, Nuhad K. Ibrahim, Francisco J. Esteva, Vicente Valero, Gabriel N. Hortobagyi, Karl L. Mettinger, Massimo Cristofanilli> ;Cancer Chemotherapy and Pharmacology. 2006 Apr 1

Journal Articles

• Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer  
  Silwan Chedid, Edgardo Rivera, Debbie K. Frye, Nuhad Ibrahim, Francisco Esteva, Vicente Valero, Gabriel Hortobagyi, Karl L. Mettinger and Massimo Cristofanilli, Cancer Chemotherapy and Pharmacology, pages540-544, volume 57, number 4, 2006, 2006
• A phase II study of capecitabine and oxaliplatin (CAPOX) in metastatic adenocarcinoma of the small bowel (SBA) or ampulla of Vater  
  M.J. Overman, S. Chedid, J. Morris, S. Waldrum and R. Wolff, Journal of Clinical Oncology, 2006 ASCO Annual Meeting proceedings (Post-Meeting Edition). Vol 24. N, 2006

Books/Book Chapters

• Acute Care of the cancer Patient 
  Chapter: Principles of Chemotherapy 
  S. Chedid and J. TrentMarcel Dekker/CRC Press, , Houston2005

Abstracts/Posters

• The Efficacy and Safety of Continued Hydroxyurea Therapy Versus Switching to Ruxolitinib in Patients with Polycythemia Vera: A Randomized, Double-Blind, Double-Dummy, ...
  Ruben Mesa, Alessandro Vannucchi, Abdulraheem Yacoub, Pierre Zachee, Mamta Garg, Roger Lyons, Silwan Chedid, Steffen Koschmieder, Ciro Rinaldi, Jennifer Byrne, Yasmin ..., Poster presentation, December 2014, at the 56th ASH Annual Meeting and Exposition in San Francisco, CA; Abstract published online in the November 14 supplemental volume of Blood., 2014
• Phase II study of Imatinib mesylate (STI-571) for patients with metastatic breast cancer (MBC) with tumors that overexpress PDGFRB and/or c-kit.
  Silwan Chedid, Daniel Booser, Savitri Krishnamurthy, James M. Reuben, Janio Saklaruk, Marjorie Green, Banu Arun, Vincente Valero, Melanie Royce, Maybelle Sison, Debbie..., Abstract #2219 Proc Amer Assoc Cancer Res, Volume 45, 2004, M.D. Anderson Cancer Center, Houston, TX, 2004
• Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
  M. Cristofanilli, J.M. Reuben, H.A. Fritsche, S.W. Kau, J. Lara, B. Arun, V. Valero, S. Chedid, G.V. Doyle, M.C. Miller, W.J. Allard, L.W. Terstappen, G.N. Hortobagyi, Poster presentation, March 2003, at the 95th Annual Meeting of the American Association for Cancer Research; abstract published in the Proceedings of the American Associations for Cancer Research, M.D. Anderson Cancer Center, Houston, TX, 2003
• Unrelated Cord Blood Transplantation in Adults
  S. L. Goldberg, S. Chedid, A. A. Jennis, R. A. Preti, and A. L. Pecora, Poster presentation, December 2000, at the 42nd American Society of Hematology Annual Meeting, Adult Blood & Marrow Stem Cell Program, Hackensack University Medical Center, Hackensack, NJ, 12/2000
• Unrelated Cord Blood Transplantation in Adults: A Single Institution Experience
  S. L. Goldberg, S. Chedid, A. A. Jennis, R. A. Preti, and A. L. Pecora, Abstract published in the proceedings of the 42nd American Society of Hematology Annual Meeting, Hackensack University Medical Center, 2000
• Difference Between Pre-freeze Total Nucleated Cell Counts of Unrelated Cord Blood Units Reported and Post-Thaw Counts Available for Patient Re-infusion
  S. L. Goldberg, J. A. Brochstein, S. Chedid, B. Adler-Brechter, T.R. Klumpp, A. L. Pecora, and R. A. Preti, Abstract published in the proceedings of the 42nd American Society of Hematology Annual Meeting., Adult/Pediatric Transplant Program, Hackensack University Medical Center, Hackensack, NJ, 2000
• Join now to see all